Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs AST SpaceMobile Inc (ASTS) Price & Performance

Amylx Pharmaceuticals IncTrade
AST SpaceMobile IncTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs AST SpaceMobile Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B), while AST SpaceMobile Inc trades at $71.88 (market cap $20.54B). The key difference: AST SpaceMobile Inc is far larger — about 7.8× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, AST SpaceMobile Inc nearer its low. Which is the better fit depends on your goals.

AMLXASTS
Market Cap
$2.64B$20.54B
Sector
HealthMedia
52-Week High
$24.19$133.09
52-Week Low
$7.82$36.91
Enterprise Value
$2.39B$21.25B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About AST SpaceMobile Inc

AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building the global cellular broadband network in space to operate directly with standard, unmodified mobile devices based on extensive IP and patent portfolio. AST is on a mission to eliminate the connectivity gaps faced by mobile subscribers and finally bring broadband to the billions who remain unconnected.

Read more on ASTS